PRESENTS

SOCIALIS
IMPULSUM
CASE BRIEF

CASE PARTNER
 Delivering the Sars-Cov-2 vaccine – Keeping India Ahead
THE CONTEXT:
With the ongoing pandemic, it is increasingly clear that only a potent vaccine when, administered to large
sections of the population, can ultimately stem the tide of new infections and the ensuing economic
challenges faced by countries across the world. India is no exception to this, but we also face challenges with
the way we will deliver the vaccine across the length and breadth of the country.

The successes of polio eradication and universal immunisation in India are indicators that there is capacity in
the system to deliver at the scale needed. However, the challenge with the administration of a potential
SARS-COV-2 vaccine are much higher. It will have to be done at a pace that has not been witnessed before,
to enable quick economic recovery. There are some key themes that need to be explored as India details out
the strategy for this

CASE QUESTIONS:
We propose that the participants in the competition attempt the below questions using a suitable analytical
framework (use correlations and data visualization to add authenticity to your argument) and arrive at
actionable insights that can be communicated to the stakeholders concerned – the medical community, the
state and central governments and also entities involved in innovations for cold storage and logistics
requirements at a local level.

What should be priority for public health entities to target the delivery of the vaccine?
Q1
a. For effective immunity this must address vulnerable groups, the ability to acquire and scale up immunity
in small clusters and larger geographies.
b. While economic considerations could play a role in availability and pricing, what must be some principles
adopted in pushing for universal availability, at the earliest

What are the cold chain capacity needs for the delivery of this vaccine?
Q2
a. There is geographic disparity within the country in this regard. How will that be addressed?
b. Are there specific technologies that India must consider, given that there is a paucity of cold chains and
the need to augment it for this vaccine and the normal course?

Hint: Should the government invest in a rigid infrastructure for cold-storage and other warehouses?
Think of the demand once the pandemic gets over and come up with solutions to effectively reduce the cost
and increase returns.

Q3 What human resource requirements do we foresee and how will that be contingent on the mode of
delivery of the vaccine?
a. How does the size of the health worker population compare with the need?

Hint: Use the datasheets provided as well use your own sources and make all reasonable assumptions
regarding the average number of people one health worker can immunise and how many are present
currently.
b. How will the vaccine delivery impact other health programmes that are underway (normal immunization
drives for instance)?

1
For the exclusive use of Socialis Impulsum Case Competition participants, August 2020.
CEEW reserves the right to use any solution in any policy recommendation/blog as they deem fit. No part of
the problem statement may be reproduced, published in any form or utilized in other places without the
permission of Talerang and CEEW.
 • Please download it and utilize all the resources found in this link
(https://drive.google.com/drive/folders/1-
GvPZU6ebMVAEVhcxQXMl28TrU4zuoyc?usp=sharing).
• We will offer additional resources and guidance through our registered email which you
will be regularly receiving. Please post all questions in this link
(https://forms.gle/JAFk7hLuFt37XwTS7) before August 5th. There might be a webinar
conducted to clarify doubts.

2
For the exclusive use of Socialis Impulsum Case Competition participants, August 2020.
CEEW reserves the right to use any solution in any policy recommendation/blog as they deem fit. No part of
the problem statement may be reproduced, published in any form or utilized in other places without the
permission of Talerang and CEEW.